PTGER4 and cardiac hypertrophy: However, due to the limited reports of EP4 in ischemic heart under complicated disease states, in this review, we thus summarize the current progress regarding the role of the PGE2-EP4 signaling in ischemic heart diseases, including cardiac hypertrophy and MI/R, which has been obtained from studies using genetic knockout mouse and pharmacological interventions.